XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,760,853 | $183,292,841 | 2.31% |
| BRAIDWELL LP | 1,828,353 | $70,391,591 | 2.30% |
| Nicholas Investment Partners, LP | 791,118 | $30,458,043 | 2.08% |
| BVF INC/IL | 1,827,958 | $70,376,383 | 1.96% |
| Redmile Group, LLC | 1,120,476 | $43,138,326 | 1.66% |
| Parkman Healthcare Partners LLC | 217,740 | $8,382,990 | 1.45% |
| Logos Global Management LP | 275,000 | $10,587,500 | 1.44% |
| Perceptive Advisors | 1,223,377 | $47,100,015 | 1.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 99,756 | $3,840,606 | 1.19% |
| Rock Springs Capital Management LP | 1,178,002 | $45,353,077 | 1.08% |
External links
This page lists XENON PHARMACEUTICALS INC's shareholders in Q2 2023. To view XENON PHARMACEUTICALS INC's shareholder history, click here.